
Europe Balloon Catheters Market Report and Forecast 2024-2032
Description
Europe Balloon Catheters Market Report and Forecast 2024-2032
Europe Balloon Catheters Market Report and Forecast 2024-2032
Europe Balloon Catheters Market Outlook
The global balloon catheters market size was valued at USD 4.5 billion in 2023, with Europe holding a significant market share. The market is driven by the increasing prevalence of cardiovascular diseases. It is expected to grow at a CAGR of 10.60% during the forecast period of 2024-2032, with the values likely to attain USD 8.1 billion by 2032.
Key Takeaways
- Recent data reveals that Eastern Europe has the highest cardiovascular disease death rates, with 553 deaths for every 100,000 individuals. The high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, drives the demand for balloon catheters in the region.
- One of the major Europe balloon catheters market trends is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Medical Devices was acquired by Translumina to expand its intervention cardiology portfolio . Such strategic partnerships are expected to increase access to innovative balloon catheters.
- The increased focus on minimally invasive surgeries significantly elevates the market value, driving both the development and adoption of balloon catheters across the region.
Balloon catheters are medical devices that are primarily utilized in minimally invasive procedures to treat narrowed or blocked vessels. The catheter is a thin and flexible tube made from medical-grade materials and a balloon is attached to its tip, which can be inflated and deflated. The rising preference for balloon catheters can be attributed to the growing demand for minimally invasive surgeries, which significantly contributes to the Europe balloon catheters market growth.
In Europe, the high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, drives the demand for balloon catheters. Recent data reveals that Eastern Europe has the highest cardiovascular disease death rates, with 553 deaths for every 100,000 individuals, indicating the urgent need for interventions that involve balloon catheters, such as angioplasty. Further, the growing aging population coupled with the presence of advanced healthcare infrastructure and high healthcare spending is expected to influence the Europe balloon catheters market share.
One of the major market trends is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Netherlands-based balloon catheter manufacturer Blue Medical Devices was acquired by a global interventional cardiovascular device company Translumina to expand its intervention cardiology portfolio. Through this acquisition, the company is expected to gain access for Drug Coated Balloons (DCB) and other specialty balloons, that can offer new treatment possibilities to cardiovascular patients. Such strategic partnerships are expected to increase access to innovative balloon catheters across the region, thereby fuelling market growth.
Europe Balloon Catheters Market Segmentation
Market Breakup by Product Type
- PTA Balloon Catheters
- PTCA Balloon Catheters
- Occlusion Balloon Catheters
- Foley Catheters
- Nephrostomy Balloon Catheters
- Drug-Eluting Catheters
- Normal Balloon Catheter
- Cutting Balloon Catheter
- Scoring Balloon Catheter
- Drug Eluting Balloon Catheter
- Stent Graft Balloon Catheter
- Others
- Fixed Wire
- Over-The-Wire
- Rapid Exchange
- Non-Compliant
- Semi-Compliant
- Compliant
- Polyurethane
- Nylon
- Others
- Coronary Artery Disease
- Peripheral Vascular Disease
- Hospitals
- Specialty Clinics
- Others
- United Kingdom
- Germany
- France
- Italy
- Others
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Becton Dickinson and Company
- Boston Scientific Corporation
- Bard Medical Division
- B.Braun Melsungen AG
- Johnson & Johnson
- Teleflex Incorporated
- Medtronic, Plc.
- Edwards Lifesciences Corporation
- Vascular Solutions, Inc.
FAQs
- What is the Europe balloon catheters market forecast outlook for 2024-2032?
- What are the major factors aiding the Europe balloon catheters market demand?
- What are the major Europe balloon catheters market trends?
- What is the market segmentation based on the product type?
- What is the market segmentation based on the catheter type?
- What is the market breakup by balloon type?
- What is the market breakup by material?
- What is the market breakup by indication?
- What are the major end users of balloon catheters in Europe?
- What is the market segmentation by countries?
- Who are the key players involved in the Europe balloon catheters market?
Meta description
The Europe balloon catheters market is poised for growth, driven by the expansion of the global balloon catheters market, which reached a value of 4.5 billion in 2023 and is projected to grow at a CAGR of 6.5% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Europe Balloon Catheters Market Overview
- 3.1 Europe Balloon Catheters Market Historical Value (2017-2023)
- 3.2 Europe Balloon Catheters Market Forecast Value (2024-2032)
- 4 Europe Balloon Catheters Market Landscape*
- 4.1 Europe Balloon Catheters: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Europe Balloon Catheters: Product Landscape
- 4.2.1 Analysis by Product Type
- 4.2.2 Analysis by Catheters Type
- 4.2.3 Analysis by Balloon Type
- 5 Europe Balloon Catheters Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Analysis
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Europe Balloon Catheters Market Segmentation (2017-2032)
- 6.1 Europe Balloon Catheters Market (2017-2032) by Product Type
- 6.1.1 Market Overview
- 6.1.2 PTA Balloon Catheters
- 6.1.3 PTCA Balloon Catheters
- 6.1.4 Occlusion Balloon Catheters
- 6.1.5 Foley Catheters
- 6.1.6 Nephrostomy Balloon Catheters
- 6.1.7 Drug -Eluting Catheters
- 6.1.8 Normal Balloon Catheter
- 6.1.9 Cutting Balloon Catheter
- 6.1.10 Scoring Balloon Catheter
- 6.1.11 Drug Eluting Balloon Catheter
- 6.1.12 Stent Graft Balloon Catheter
- 6.1.13 Others
- 6.2 Europe Balloon Catheters Market (2017-2032) by Catheter Type
- 6.2.1 Market Overview
- 6.2.2 Fixed Wire
- 6.2.3 Over -The -Wire
- 6.2.4 Rapid Exchange
- 6.3 Europe Balloon Catheters Market (2017-2032) by Balloon Type
- 6.3.1 Market Overview
- 6.3.2 Non-Compliant
- 6.3.3 Semi-Compliant
- 6.3.4 Compliant
- 6.4 Europe Balloon Catheters Market (2017-2032) by Material
- 6.4.1 Market Overview
- 6.4.2 Polyurethane
- 6.4.3 Nylon
- 6.4.4 Others
- 6.5 Europe Balloon Catheters Market (2017-2032) by Indication
- 6.5.1 Market Overview
- 6.5.2 Coronary Artery Disease
- 6.5.3 Peripheral Vascular Disease
- 6.6 Europe Balloon Catheters Market (2017-2032) by End User
- 6.6.1 Market Overview
- 6.6.2 Hospitals
- 6.6.3 Specialty Clinics
- 6.6.4 Others
- 6.7 Europe Balloon Catheters Market (2017-2032) by Countries
- 6.7.1 Market Overview
- 6.7.2 United Kingdom
- 6.7.3 Germany
- 6.7.4 France
- 6.7.5 Italy
- 6.7.6 Others
- 7 United Kingdom Balloon Catheters Market (2017-2032)
- 7.1 United Kingdom Balloon Catheters Market (2017-2032) by Product Type
- 7.1.1 Market Overview
- 7.1.2 PTA Balloon Catheters
- 7.1.3 PTCA Balloon Catheters
- 7.1.4 Occlusion Balloon Catheters
- 7.1.5 Foley Catheters
- 7.1.6 Nephrostomy Balloon Catheters
- 7.1.7 Drug -Eluting Catheters
- 7.1.8 Normal Balloon Catheter
- 7.1.9 Cutting Balloon Catheter
- 7.1.10 Scoring Balloon Catheter
- 7.1.11 Drug Eluting Balloon Catheter
- 7.1.12 Stent Graft Balloon Catheter
- 7.1.13 Others
- 7.2 United Kingdom Balloon Catheters Market (2017-2032) by Catheter Type
- 7.2.1 Market Overview
- 7.2.2 Fixed Wire
- 7.2.3 Over -The -Wire
- 7.2.4 Rapid Exchange
- 7.3 United Kingdom Balloon Catheters Market (2017-2032) by Balloon Type
- 7.3.1 Market Overview
- 7.3.2 Non-Compliant
- 7.3.3 Semi-Compliant
- 7.3.4 Compliant
- 7.4 United Kingdom Balloon Catheters Market (2017-2032) by Material
- 7.4.1 Market Overview
- 7.4.2 Polyurethane
- 7.4.3 Nylon
- 7.4.4 Others
- 7.5 United Kingdom Balloon Catheters Market (2017-2032) by Indication
- 7.5.1 Market Overview
- 7.5.2 Coronary Artery Disease
- 7.5.3 Peripheral Vascular Disease
- 7.6 United Kingdom Balloon Catheters Market (2017-2032) by End User
- 7.6.1 Market Overview
- 7.6.2 Hospitals
- 7.6.3 Specialty Clinics
- 7.6.4 Others
- 8 Germany Ballon Catheters Market (2017-2032)
- 8.1 Germany Balloon Catheters Market (2017-2032) by Product Type
- 8.1.1 Market Overview
- 8.1.2 PTA Balloon Catheters
- 8.1.3 PTCA Balloon Catheters
- 8.1.4 Occlusion Balloon Catheters
- 8.1.5 Foley Catheters
- 8.1.6 Nephrostomy Balloon Catheters
- 8.1.7 Drug -Eluting Catheters
- 8.1.8 Normal Balloon Catheter
- 8.1.9 Cutting Balloon Catheter
- 8.1.10 Scoring Balloon Catheter
- 8.1.11 Drug Eluting Balloon Catheter
- 8.1.12 Stent Graft Balloon Catheter
- 8.1.13 Others
- 8.2 Germany Balloon Catheters Market (2017-2032) by Catheter Type
- 8.2.1 Market Overview
- 8.2.2 Fixed Wire
- 8.2.3 Over -The -Wire
- 8.2.4 Rapid Exchange
- 8.3 Germany Balloon Catheters Market (2017-2032) by Balloon Type
- 8.3.1 Market Overview
- 8.3.2 Non-Compliant
- 8.3.3 Semi-Compliant
- 8.3.4 Compliant
- 8.4 Germany Balloon Catheters Market (2017-2032) by Material
- 8.4.1 Market Overview
- 8.4.2 Polyurethane
- 8.4.3 Nylon
- 8.4.4 Others
- 8.5 Germany Balloon Catheters Market (2017-2032) by Indication
- 8.5.1 Market Overview
- 8.5.2 Coronary Artery Disease
- 8.5.3 Peripheral Vascular Disease
- 8.6 Germany Balloon Catheters Market (2017-2032) by End User
- 8.6.1 Market Overview
- 8.6.2 Hospitals
- 8.6.3 Specialty Clinics
- 8.6.4 Others
- 9 France Ballon Catheters Market (2017-2032)
- 9.1 France Balloon Catheters Market (2017-2032) by Product Type
- 9.1.1 Market Overview
- 9.1.2 PTA Balloon Catheters
- 9.1.3 PTCA Balloon Catheters
- 9.1.4 Occlusion Balloon Catheters
- 9.1.5 Foley Catheters
- 9.1.6 Nephrostomy Balloon Catheters
- 9.1.7 Drug -Eluting Catheters
- 9.1.8 Normal Balloon Catheter
- 9.1.9 Cutting Balloon Catheter
- 9.1.10 Scoring Balloon Catheter
- 9.1.11 Drug Eluting Balloon Catheter
- 9.1.12 Stent Graft Balloon Catheter
- 9.1.13 Others
- 9.2 France Balloon Catheters Market (2017-2032) by Catheter Type
- 9.2.1 Market Overview
- 9.2.2 Fixed Wire
- 9.2.3 Over -The -Wire
- 9.2.4 Rapid Exchange
- 9.3 France Balloon Catheters Market (2017-2032) by Balloon Type
- 9.3.1 Market Overview
- 9.3.2 Non-Compliant
- 9.3.3 Semi-Compliant
- 9.3.4 Compliant
- 9.4 France Balloon Catheters Market (2017-2032) by Material
- 9.4.1 Market Overview
- 9.4.2 Polyurethane
- 9.4.3 Nylon
- 9.4.4 Others
- 9.5 France Balloon Catheters Market (2017-2032) by Indication
- 9.5.1 Market Overview
- 9.5.2 Coronary Artery Disease
- 9.5.3 Peripheral Vascular Disease
- 9.6 France Balloon Catheters Market (2017-2032) by End User
- 9.6.1 Market Overview
- 9.6.2 Hospitals
- 9.6.3 Specialty Clinics
- 9.6.4 Others
- 10 Italy Ballon Catheters Market (2017-2032)
- 10.1 Italy Balloon Catheters Market (2017-2032) by Product Type
- 10.1.1 Market Overview
- 10.1.2 PTA Balloon Catheters
- 10.1.3 PTCA Balloon Catheters
- 10.1.4 Occlusion Balloon Catheters
- 10.1.5 Foley Catheters
- 10.1.6 Nephrostomy Balloon Catheters
- 10.1.7 Drug -Eluting Catheters
- 10.1.8 Normal Balloon Catheter
- 10.1.9 Cutting Balloon Catheter
- 10.1.10 Scoring Balloon Catheter
- 10.1.11 Drug Eluting Balloon Catheter
- 10.1.12 Stent Graft Balloon Catheter
- 10.1.13 Others
- 10.2 Italy Balloon Catheters Market (2017-2032) by Catheter Type
- 10.2.1 Market Overview
- 10.2.2 Fixed Wire
- 10.2.3 Over -The -Wire
- 10.2.4 Rapid Exchange
- 10.3 Italy Balloon Catheters Market (2017-2032) by Balloon Type
- 10.3.1 Market Overview
- 10.3.2 Non-Compliant
- 10.3.3 Semi-Compliant
- 10.3.4 Compliant
- 10.4 Italy Balloon Catheters Market (2017-2032) by Material
- 10.4.1 Market Overview
- 10.4.2 Polyurethane
- 10.4.3 Nylon
- 10.4.4 Others
- 10.5 Italy Balloon Catheters Market (2017-2032) by Indication
- 10.5.1 Market Overview
- 10.5.2 Coronary Artery Disease
- 10.5.3 Peripheral Vascular Disease
- 10.6 Italy Balloon Catheters Market (2017-2032) by End User
- 10.6.1 Market Overview
- 10.6.2 Hospitals
- 10.6.3 Specialty Clinics
- 10.6.4 Others
- 11 Regulatory Framework
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Funding and Investment Analysis
- 13.1 Analysis by Funding Instances
- 13.2 Analysis by Type of Funding
- 13.3 Analysis by Funding Amount
- 13.4 Analysis by Leading Players
- 13.5 Analysis by Leading Investors
- 13.6 Analysis by Geography
- 14 Partnership and Collaborations Analysis
- 14.1 Analysis by Partnership Instances
- 14.2 Analysis by Type of Partnership
- 14.3 Analysis by Leading Players
- 14.4 Analysis by Geography
- 15 Supplier Landscape
- 15.1 Market Share by Top 5 Companies
- 15.2 Abbott Laboratories
- 15.2.1 Financial Analysis
- 15.2.2 Product Portfolio
- 15.2.3 Demographic Reach and Achievements
- 15.2.4 Mergers and Acquisitions
- 15.2.5 Certifications
- 15.3 Becton Dickinson and Company
- 15.3.1 Financial Analysis
- 15.3.2 Product Portfolio
- 15.3.3 Demographic Reach and Achievements
- 15.3.4 Mergers and Acquisitions
- 15.3.5 Certifications
- 15.4 Boston Scientific Corporation
- 15.4.1 Financial Analysis
- 15.4.2 Product Portfolio
- 15.4.3 Demographic Reach and Achievements
- 15.4.4 Mergers and Acquisitions
- 15.4.5 Certifications
- 15.5 Bard Medical Division
- 15.5.1 Financial Analysis
- 15.5.2 Product Portfolio
- 15.5.3 Demographic Reach and Achievements
- 15.5.4 Mergers and Acquisitions
- 15.5.5 Certifications
- 15.6 B.Braun Melsungen AG
- 15.6.1 Financial Analysis
- 15.6.2 Product Portfolio
- 15.6.3 Demographic Reach and Achievements
- 15.6.4 Mergers and Acquisitions
- 15.6.5 Certifications
- 15.7 Johnson & Johnson
- 15.7.1 Financial Analysis
- 15.7.2 Product Portfolio
- 15.7.3 Demographic Reach and Achievements
- 15.7.4 Mergers and Acquisitions
- 15.7.5 Certifications
- 15.8 Teleflex Incorporated
- 15.8.1 Financial Analysis
- 15.8.2 Product Portfolio
- 15.8.3 Demographic Reach and Achievements
- 15.8.4 Mergers and Acquisitions
- 15.8.5 Certifications
- 15.9 Medtronic, Plc.
- 15.9.1 Financial Analysis
- 15.9.2 Product Portfolio
- 15.9.3 Demographic Reach and Achievements
- 15.9.4 Mergers and Acquisitions
- 15.9.5 Certifications
- 15.10 Edwards Lifesciences Corporation
- 15.10.1 Financial Analysis
- 15.10.2 Product Portfolio
- 15.10.3 Demographic Reach and Achievements
- 15.10.4 Mergers and Acquisitions
- 15.10.5 Certifications
- 15.11 Vascular Solutions,Inc.
- 15.11.1 Financial Analysis
- 15.11.2 Product Portfolio
- 15.11.3 Demographic Reach and Achievements
- 15.11.4 Mergers and Acquisitions
- 15.11.5 Certifications
- 16 Europe Balloon Catheters Market - Distribution Model (Additional Insight)
- 16.1 Overview
- 16.2 Potential Distributors
- 16.3 Key Parameters for Distribution Partner Assessment
- 17 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 18 Company Competitiveness Analysis (Additional Insight)
- 18.1 Very Small Companies
- 18.2 Small Companies
- 18.3 Mid-Sized Companies
- 18.4 Large Companies
- 18.5 Very Large Companies
- 19 Payment Methods (Additional Insight)
- 19.1 Government Funded
- 19.2 Private Insurance
- 19.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.